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D
eep anterior lamellar keratoplasty (DALK) that only replaces the diseased part of the cornea while preserving the recipient's Descemet membrane and endothelium minimizes the complications of replacing the full-thickness cornea [penetrating keratoplasty (PK)] [1] [2] . Moreover, improvements in DALK techniques have also enhanced its usefulness for treatment of corneal disease in patients with non-compromised endothelium [3] [4] . Although less than that associated with PK [5] [6] , the risk of recurrence and graft rejection episodes after DALK also exists, potentially leaving a mild to moderate corneal opacity.
In modern China, keratoplasty still faces many challenges, including the large numbers of patients, a lack of corneal donors, and limited medical funding [7] . These challenges greatly reduce the chance of a patient receiving another keratoplasty after suffering a mild to moderate corneal opacity after the first procedure. In patients with coexisting cataracts, capsulorhexis and phacoemulsification are difficult because of poor visibility of the crystalline lens and anterior capsule [8] . The protection of the graft and endothelium should also be considered during operation. Previous studies have shown that phacoemulsification after DALK is safe and provides an improvement in the visual acuity of eyes with transparent corneas [4, [9] [10] . But few studies are available on phacoemulsification in eyes with mild to moderate corneal opacities after DALK. To overcome above difficulties, we performed a non-invasive optical fiber illumination-assisted phacoemulsification and IOL implantation procedure in eyes with mild to moderate corneal opacities after DALK and the efficacy of the procedure was evaluated. phacomorphic glaucoma during the follow-up period after DALK. Eyes with severe corneal opacities, active inflammation, lens dislocation, and fundus lesions were excluded. Pre-phaco Examination Corrected distance visual acuity (CDVA) and slit-lamp microscopic examination were performed in all eyes. Intraocular pressure (IOP) was measured by a Tono-Pen (SW-500; SUOER, China). Endothelial cell density (ECD) was detected by confocal microscopy (Confoscan 3.0; NIDEK, Japan). The axial length was measured by partial coherence interferometry (PCI; IOLMaster 500; Carl Zeiss, Germany). Keratometry readings were obtained using corneal topography (ATLAS 9000; Carl Zeiss, Germany) and then manually inserted into the PCI device to determine the spherical IOL power using the SRK-T formula. surgical technique All operations were performed by the same senior surgeon (Bi YL) under retrobulbar anesthesia. Care was taken to avoid contact with the graft-host junction when making two corneoscleral limbus incisions. Through a 2.7 mm corneoscleral limbus incision, an air bubble was injected into the anterior chamber. Of 0.1% trypan blue was injected over the anterior capsule within the air bubble to improve visibility of the capsule and a viscoelastic substance was then used to maintain the anterior chamber ( Figure 1A ). Adjusting the surgical microscope to smaller aperture and higher coaxial illumination would provide a deeper depth of field, which can improve the distinguishability of the lens to some degree ( Figure 1B ). But in these cases, the above steps would not provide enough visibility for the subsequent procedure. Considering this, a non-invasive optical fiber used as the only light source to further enhance visibility. With an appropriate projection angle and distance, the lens can be observed clearly ( Figure 1C ). The continuous curvilinear capsulorhexis and hydrodissection were performed conventionally. Phacoemulsification was performed using a divide-and-conquer technique with a low vacuum and flow rate ( Figure 1D ). After the implantation of a foldable IOL and aspiration of the viscoelastic substance, the incisions were hydrated closed. Post-phaco Protocol All eyes received levofloxacin 0.5%, TobraDex (tobramycin 0.3% and dexamethasone 0.1%) and pranoprofen 0.1% eye drops postoperatively, which were gradually tapered and then stopped after one month. Patients received follow-up regularly after discharge. CDVA, IOP, ECD, and slit-lamp microscopic examination accompanied each visit. Statistical Analysis Statistical analyses were performed using SPSS 11.0. Data were shown as mean±SD. Comparisons between pre-phaco and post-phaco ECD were performed using a pared-samples t-test. P<0.05 was considered statistically significant.
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RESULTS AND DISCUSSION
Twelve eyes of 12 patients were included in the study and the patient characteristics are shown in Table 1 . The mean age was 61.33±5.76y. The mean interval between DALK and phacoemulsification was 13.50±3.48mo. For a final accurate prediction of IOL power, phacoemulsification was performed in all eyes after full suture removal [11] (at least 12mo after DALK; Figures 2-3) , except for one eye ( Figure 1E ) with preexisting posterior synechia presenting phacomorphic glaucoma beyond the control of topical antiglaucoma medications during the follow-up period after DALK. The IOP in this eye maintained between 32 to 38 mm Hg with three medications (pilocarpine 0.5%, carteolol 2% and brimonidine 0.2% eye drops). Mannitol 20% given one-half hour before operation reduced IOP to 25 mm Hg and phacoemulsification with lysis of the posterior synechia and goniosynechialysis was performed four months after DALK. Post-phaco IOP of this eye maintained between 14 to 20 mm Hg without medications, and the graft was stable without edema ( Figure 1F ). Glaucoma is well recognized as an independent cause of keratoplasty failure [12] [13] , so the timing of surgery is crucial. One article reported a case in which phacoemulsification was performed four months after DALK and no intraoperative or postoperative complications were noted [4] . Likewise, the case in this study also suggests that phacoemulsification after DALK is safe with an interval of four months. [14] [15] and 2-stage procedure [4] are available. Although the triple procedure enables faster recovery and fewer follow-up visits, inaccuracy in IOL power prediction is a major drawback [15] . Moreover, the need for cataract surgery may emerge after keratoplasty in eyes with no preexisting lenticular changes or severe corneal opacity limiting the preoperative detection of cataracts. So, the 2-stage procedure is still required in many cases. Performing phacoemulsification in eyes with preexisting corneal opacities is challenging because of poor visibility of the lens and anterior chamber. Anterior chamber endoillumination and transconjunctival chandelier retroillumination have reportedly been used in cataract surgery to enhance visibility [8, 16] .
But these procedures also have limits. Anterior chamber endoillumination occupies space in the anterior chamber and the position is inconvenient to change. Transconjunctival chandelier retroillumination used in vitreoretinal surgery may result in retinal phototoxicity [17] [18] [19] . In this study, a noninvasive optical fiber was used as the only light source to decrease the light scatter caused by corneal opacity and further enhance visibility. The non-invasive optical fiber does not need additional incisions and has smaller influence on the cornea, which is especially important in eyes after DALK. Further, it has better mobility and does not occupy the space of the anterior chamber, making anterior chamber manipulation progress more smoothly. The slant projection angle also reduces microscope-induced retinal phototoxicity [20] [21] . After solving the problem of illumination, the other thing to be noticed is the protection of the graft and endothelium. Corneoscleral limbus incisions should avoid contact with the graft-host junction. Staining of the anterior capsule under an air bubble reduced contact between the dye and the corneal endothelium. Minimize movement of the tip to reduce its influence on the graft-host junction. A low vacuum and flow rate were required to decrease turbulence in the anterior chamber and to minimize the damage to the graft-host junction and endothelium. For safety, this technique should be performed in eyes with a nucleus up to grade Ⅲ (according to the Emery-Little classification), to decrease endothelial cell loss caused by high ultrasonic energy [14, 22] . There were also some limitations in this study, such as the small sample size and the need for an assistant during the surgery. More appropriate cases will be comprised in the future. Moreover, the holder for the non-invasive optical fiber is in the design. In conclusion, for patients with coexisting cataracts and mild to moderate corneal opacities after keratoplasty but who are unable to undergo another keratoplasty due to a lack of corneal donors or financial concerns, this study provided a safe and valid technique for enhancing their postoperative visual acuity to some extent and at lower cost.
